FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year

Some vaccine advisers to the federal government say they’re “disappointed” and “angry” that government scientists and the pharmaceutical company Moderna didn’t present a set of infection data on the company’s new Covid-19 booster during meetings last year when the advisers discussed whether the shot should be authorized and made available to the public.

FDA Authorizes Bivalent COVID-19 Boosters; CDC Sign-Off Expected By Weekend - State of Delaware News

BNT162b2 Vaccine Booster and Mortality Due to Covid-19

FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year

FDA Vaccine Advisor Warns Against #COVID Boosters for Healthy Young People - NTD Good Morning

MedWatch

How Full FDA Approval Could Spur Vaccination

U.S. FDA advisers recommend change to COVID vaccine composition for fall

Is FDA's Disappointment Over COVID-19 Vaccine Booster Warranted?

FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year

Novak Djokovic to Play at U.S. Open After COVID-19 Policy Change – SportsTravel

Fact check: Claim misleads on FDA panel's recommendation on booster